Search research articles
Contact Us
Filters
Showing results (331-340 of 356) with videos related to
Page
of 36
Sort By:
Trials
|
October 24, 2023
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder
Orli S Schwartz, Paul Amminger, Bernard T Baune, et al.
Trials
|
April 29, 2026
Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic risk
Phyo Pyae Nyein, Hila Haskelberg, Marianne Martinello, et al.
Lancet (London, England)
|
September 1, 2021
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
Philip Joseph, Gholamreza Roshandel, Peggy Gao, et al.
Diabetes, Obesity & Metabolism
|
July 16, 2025
Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset
Hannah Wallace, James Wick, Brendon L Neuen, et al.
Journal of Affective Disorders
|
May 29, 2025
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS study
Mary Lou Chatterton, Johana Kevin Perez, Thao Thai, et al.
American Heart Journal
|
August 25, 2024
Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: Rationale and design of the CRAFT trial
Chao Jiang, Zhiyan Wang, Xin Du, et al.
Heart (British Cardiac Society)
|
June 30, 2018
Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials
Vanessa Selak, Ruth Webster, Sandrine Stepien, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
July 6, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study
Nick Glozier, Richard Morris, Elizabeth Stratton, et al.
Circulation
|
October 21, 2016
Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus
Zahir H Alshehry, Piyushkumar A Mundra, Christopher K Barlow, et al.
Eclinicalmedicine
|
July 18, 2019
Effects of continuous positive airway pressure on depression and anxiety symptoms in patients with obstructive sleep apnoea: results from the sleep apnoea cardiovascular Endpoint randomised trial and meta-analysis
Danni Zheng, Ying Xu, Shoujiang You, et al.
Page
of 36
Search research articles
Search
Showing results (331-340 of 356) with videos related to
Sort By:
Page
of 36
Trials
|
October 24, 2023
The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder
Orli S Schwartz, Paul Amminger, Bernard T Baune, et al.
Trials
|
April 29, 2026
Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic risk
Phyo Pyae Nyein, Hila Haskelberg, Marianne Martinello, et al.
Lancet (London, England)
|
September 1, 2021
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
Philip Joseph, Gholamreza Roshandel, Peggy Gao, et al.
Diabetes, Obesity & Metabolism
|
July 16, 2025
Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset
Hannah Wallace, James Wick, Brendon L Neuen, et al.
Journal of Affective Disorders
|
May 29, 2025
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS study
Mary Lou Chatterton, Johana Kevin Perez, Thao Thai, et al.
American Heart Journal
|
August 25, 2024
Protocol for a randomized controlled trial of intensive blood pressure control on cardiovascular risk reduction in patients with atrial fibrillation: Rationale and design of the CRAFT trial
Chao Jiang, Zhiyan Wang, Xin Du, et al.
Heart (British Cardiac Society)
|
June 30, 2018
Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials
Vanessa Selak, Ruth Webster, Sandrine Stepien, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
July 6, 2026
Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study
Nick Glozier, Richard Morris, Elizabeth Stratton, et al.
Circulation
|
October 21, 2016
Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus
Zahir H Alshehry, Piyushkumar A Mundra, Christopher K Barlow, et al.
Eclinicalmedicine
|
July 18, 2019
Effects of continuous positive airway pressure on depression and anxiety symptoms in patients with obstructive sleep apnoea: results from the sleep apnoea cardiovascular Endpoint randomised trial and meta-analysis
Danni Zheng, Ying Xu, Shoujiang You, et al.
Page
of 36